Skip to main content
. 2012 Jan 1;18(1):BR24–BR32. doi: 10.12659/MSM.882196

Table 7.

DNA content in each phase of HSCs after 18α-GL treatment (x±s, n=3).

18α-GL (mg/ml) G0/G1 (%) S (%) G2/M (%)
0 (control) 29.9±3.5 65.7±3.3 4.5±0.5
0.1 28.3±1.7 66.7±3.1 5.0±1.4
1 29.8±1.7 58.8±1.1 11.4±0.6*
*

P<0.001 vs. control group.